PHOSPHORUS-CONTAINING INHIBITORS OF HMG-COA REDUCTASE .3. SYNTHESIS OF HYDROXYPHOSPHINYL-ANALOGS OF THE MEVINIC ACIDS

被引:8
|
作者
KARANEWSKY, DS [1 ]
BADIA, MC [1 ]
机构
[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,PRINCETON,NJ 08543
关键词
D O I
10.1016/S0040-4039(00)60052-7
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The synthesis of a series of hydroxyphosphinyl-containing analogues of the HMG-CoA reductase inhibitor trans-tetrahydrocompactin is described.
引用
收藏
页码:39 / 42
页数:4
相关论文
共 50 条
  • [21] Synthesis and Biological Evaluation of Atorvastatin Derivatives as Novel HMG-CoA Reductase Inhibitors
    Tong, Jiayi
    Wang, Naxin
    Xiao, Hua
    LETTERS IN DRUG DESIGN & DISCOVERY, 2013, 10 (09) : 817 - 822
  • [22] Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors
    Pfefferkorn, Jeffrey A.
    Song, Yuntao
    Sun, Kuai-Lin
    Miller, Steven R.
    Trivedi, Bharat K.
    Choi, Chulho
    Sorenson, Roderick J.
    Bratton, Larry D.
    Unangst, Paul C.
    Larsen, Scott D.
    Poel, Toni-Jo
    Cheng, Xue-Min
    Lee, Chitase
    Erasga, Noe
    Auerbach, Bruce
    Askew, Valerie
    Dillon, Lisa
    Hanselman, Jeffrey C.
    Lin, Zhiwu
    Lu, Gina
    Robertson, Andrew
    Olsen, Karl
    Mertz, Thomas
    Sekerke, Catherine
    Pavlovsky, Alexander
    Harris, Melissa S.
    Bainbridge, Graeme
    Caspers, Nicole
    Chen, Huifen
    Eberstadt, Matthias
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4538 - 4544
  • [23] Synthesis and biological evaluations of quinoline-based HMG-CoA reductase inhibitors
    Suzuki, M
    Iwasaki, H
    Fujikawa, Y
    Kitahara, M
    Sakashita, M
    Sakoda, R
    BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (10) : 2727 - 2743
  • [24] Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: Possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitors
    Lee, Chong-Ki
    Choi, Jun-Shik
    Choi, Dong-Hyun
    PHARMACOLOGICAL REPORTS, 2015, 67 (01) : 44 - 51
  • [25] Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: Possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitors
    Chong-Ki Lee
    Jun-Shik Choi
    Dong-Hyun Choi
    Pharmacological Reports, 2015, 67 : 44 - 51
  • [26] Development of a practical synthesis of novel, pyrrole-based HMG-CoA reductase inhibitors
    Pfefferkorn, Jeffrey A.
    Bowles, Daniel M.
    Kissel, William
    Boyles, David C.
    Choi, Chulho
    Larsen, Scott D.
    Song, Yuntao
    Sun, Kuai-Lin
    Miller, Steven R.
    Trivedi, Bharat K.
    TETRAHEDRON, 2007, 63 (34) : 8124 - 8134
  • [27] Dual effects of HMG-CoA reductase inhibitors on vascular endothelial growth factor synthesis
    Frick, M
    Dulak, J
    Zwick, R
    Alber, H
    Dichtl, W
    Schwarzacher, SR
    Pachinger, O
    Weidinger, F
    EUROPEAN HEART JOURNAL, 2002, 23 : 422 - 422
  • [28] REGULATION OF CHOLESTEROL-SYNTHESIS BY A NEW CLASS OF NONCOMPETITIVE INHIBITORS OF HMG-COA REDUCTASE
    STACPOOLE, PW
    HARWOOD, HJ
    VARNADO, CE
    DIABETES, 1983, 32 : A62 - A62
  • [29] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF INDAZOLE-DERIVED HMG-COA REDUCTASE INHIBITORS
    KIM, JI
    JAHNG, YD
    ARCHIVES OF PHARMACAL RESEARCH, 1995, 18 (03) : 206 - 212
  • [30] An evaluation of CYP3A4 drug interactions with HMG-CoA reductase inhibitors
    White, CM
    FORMULARY, 2000, 35 (04) : 343 - +